CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
+21.62%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$565M
AUM Growth
+$156M
(+38%)
Cap. Flow
+$85.6M
Cap. Flow
% of AUM
15.14%
Top 10 Holdings %
Top 10 Hldgs %
58.05%
Holding
34
New
7
Increased
13
Reduced
–
Closed
3
Top Buys
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$10.7M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$10.1M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
+$8.74M |
| 4 |
Illumina
ILMN
|
+$6.5M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$6.17M |
Top Sells
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
+$2.67M |
| 2 |
Gilead Sciences
GILD
|
+$2.15M |
| 3 |
Ovid Therapeutics
OVID
|
+$1.58M |
Sector Composition
| 1 | Healthcare | 89.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neogen
NEOG
$1.19B
| $4.35M | 0.77% |
+130,000
| New | +$4.35M |
|
27
OraSure Technologies
OSUR
$242M
| $4.05M | 0.71% |
+240,000
| New | +$4.05M |
|
28
Zai Lab
ZLAB
$3.65B
| $2.88M | 0.51% |
+135,000
| New | +$2.88M |
|
29
Adverum Biotechnologies
ADVM
$63.4M
| $1.74M | 0.31% |
+30,000
| New | +$1.74M |
|
30
Q32 Bio
QTTB
$23.5M
| $1.12M | 0.2% |
+3,333
| New | +$1.12M |
|
|
31
Gilead Sciences
GILD
$142B
| – | – |
-30,000
| Closed | -$2.15M |
|
|
32
Ovid Therapeutics
OVID
$89.6M
| – | – |
-160,000
| Closed | -$1.58M |
|
|
SYRS
33
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – |
-27,407
| Closed | -$2.67M |
|
|
CELG
34
DELISTED
Celgene Corp
CELG
| – | – |
0
| – | – |
|